Two Sigma Securities’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,600
Closed -$631K 3291
2024
Q1
$631K Buy
4,600
+1,200
+35% +$164K 0.01% 1414
2023
Q4
$462K Buy
+3,400
New +$415K ﹤0.01% 1610
2021
Q4
Sell
-4,700
Closed -$760K 1766
2021
Q3
$760K Buy
+4,700
New +$791K 0.02% 610
2021
Q1
Sell
-28,200
Closed -$4.27M 1242
2020
Q4
$4.27M Buy
28,200
+22,600
+404% +$3.23M 0.1% 125
2020
Q3
$758K Buy
5,600
+1,600
+40% +$217K 0.02% 436
2020
Q2
$547K Sell
4,000
-10,600
-73% -$1.35M 0.01% 604
2020
Q1
$1.57M Sell
14,600
-120,700
-89% -$13.9M 0.04% 285
2019
Q4
$16.3M Buy
135,300
+52,500
+63% +$5.86M 0.11% 133
2019
Q3
$8.24M Buy
82,800
+10,100
+14% +$1.06M 0.08% 196
2019
Q2
$7.93M Sell
72,700
-62,800
-46% -$6.68M 0.08% 148
2019
Q1
$15.1M Sell
135,500
-41,600
-23% -$4.56M 0.14% 70
2018
Q4
$17.1M Buy
177,100
+117,600
+198% +$12.5M 0.21% 49
2018
Q3
$7.25M Sell
59,500
-185,100
-76% -$21.8M 0.05% 283
2018
Q2
$26.9M Buy
244,600
+11,500
+5% +$1.23M 0.13% 114
2018
Q1
$24.9M Buy
233,100
+198,900
+582% +$22M 0.14% 124
2017
Q4
$3.65M Buy
34,200
+30,300
+777% +$3.24M 0.1% 158
2017
Q3
$434K Buy
+3,900
New +$417K 0.04% 291

Other funds holding IBB

Two Sigma Securities's IBB Position: Q1 2026 in Review

Two Sigma Securities sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 3,373 shares — an estimated $569K sold.

Two Sigma Securities first reported a position in IBB in Q1 2015 and held it in 28 quarters. The position peaked at $12.4M in Q1 2017. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Two Sigma Securities reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 3,373 iShares Biotechnology ETF shares in Q1 2026, an estimated $569K.
  • Two Sigma Securities first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 28 quarters.
  • Two Sigma Securities's iShares Biotechnology ETF position peaked at $12.4M in Q1 2017.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.